Drugs / SPARC1203
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01614691 | Jun → Nov 2012 | allergic rhinitis | Sun Pharma Advanced Research Company Limited | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPARC1203 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01614691 ↗ |